Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients

Histopathology

Volumn 50, Issue 6, 2007, Pages 764-772

  Satzger, I ^a   Volker B ^a   Al Ghazal, M ^a   Meier, A ^a   Kapp, A ^a   Gutzmer, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Histology; Melanoma; Prognosis; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MELANOMA; MELANOMA CELL; MICROMETASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 34247608795     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02681.x     Document Type: Article

References (27)

1. Gutzmer R, Al Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br. J. Dermatol. 2005 153 1137 1141.
2. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001 19 3635 3648.
3. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann. Surg. Oncol. 2003 10 575 581.
4. Ranieri JM, Wagner JD, Azuaje R et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann. Surg. Oncol. 2002 9 975 981.
5. Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am. J. Surg. Pathol. 2005 29 305 317.
6. McMasters KM. Melanoma controversies: clinical significance of nodal micrometastases and the future of melanoma vaccines. World J. Surg. 2005 29 681 682.
7. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann. Surg. Oncol. 2004 11 162S 168S.
8. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod. Pathol. 2004 17 747 755.
9. Vuylsteke RJ, Borgstein PJ, van Leeuwen PA et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann. Surg. Oncol. 2005 12 440 448.
10. Gutzmer R, Kaspari M, Brodersen JP et al. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies. Histopathology 2002 41 510 518.
11. Kaufmann R, Tilgen W, Garbe C. [Malignant melanoma. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V.]. Hautarzt 1998 48 (Suppl. 1 S30 S38.
12. Cochran AJ, Balda BR, Starz H et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000 89 236 241.
13. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J. Clin. Pathol. 1999 52 922 924.
14. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J. Clin. Pathol. 1999 52 871 873.
15. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Quantification of eosinophilic granule protein deposition in biopsies of inflammatory skin diseases by automated image analysis of highly sensitive immunostaining. Anal. Cell Pathol. 1999 19 153 162.
16. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br. J. Dermatol. 2001 145 720 729.
17. Scolyer RA, Li LX, McCarthy SW et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am. J. Clin. Pathol. 2004 122 532 539.
18. Scolyer RA, Thompson JF, McCarthy SW. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004 101 2141 2142.
19. Wascher RA. Pitfalls in the use of rt-PCR as a prognostic indicator in melanoma. J. Clin. Oncol. 2005 23 3863 3864.
20. Ulmer A, Fischer JR, Schanz S et al. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes. Clin. Cancer Res. 2005 11 5425 5432.
21. Greene FL, Page DL, Fleming ID et al. AJCC cancer staging manual. New York, Berlin, Heidelberg: Springer Verlag 2002.
22. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997 80 1188 1197.
23. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann. Surg. 1990 212 125 131.
24. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch. Surg. 1989 124 1051 1055.
25. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann. Surg. 1991 214 627 636.
26. Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001 91 2110 2121.
27. Cascinelli N, Clemente C, Bifulco C et al. Do patients with tumor-positive sentinel nodes constitute a homogeneous group? Ann. Surg. Oncol. 2001 8 35S 37S.